Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion
Hua Ai,Xin-Guang Yang,Run-Sheng Wang,Xiao-Hui Xue,Bin Guo
DOI: https://doi.org/10.3969/j.issn.1672-5123.2006.06.061
IF: 1.645
2006-01-01
International Journal of Ophthalmology
Abstract:AIM:To investigate the efficacy of intravitreous injection with triamcinolone acetonide(TA) for macular edema(ME) due to central retinal vein occlusion(CRVO) .METHODS:Medical records of 37 eyes of 37 patients were retrospectively reviewed that were injected with 4 mg of intravitreal TA for treatment of ME due to CRVO.Of the 37 eyes,including 33 non-ischemic and 4 ischemic CRVO,20 were injected once,15 twice and 2 three injections.Mean follow-up time was 9 months(range,3-27 months) .The average time between onset of symptoms and first injection was 2.7 months(range,0.3-9 months) .Available documents on pre-and post-injection best corrected visual acuity,intraocular pressure,slit lamp microscope check,fundus fluorescein angiography(FFA) and optical coherence tomography(OCT) central foveal thickness were evaluated.RESULTS:The average visual acuity(VA) was 0.08(range,0.01-0.4) before the treatment;while between 1 and 3 months after the injection,the best corrected VA improved in 25 patients,did not change in 3 eyes and worsened in 9 eyes.Of the 25 improved eyes,12 eyes gained more than 3 lines of VA,10 eyes improved by 2 lines and 3 eyes by 1 line.After then,some worsened and unimproved eyes received the second or the third injection.At the last follow-up,he best corrected VA improved in 24 eyes,did not change in 3 eyes and worsened in 10 eyes.Of the improved eyes,3 eyes gained more than 3 lines of visual acuity,10 eyes improved by 2 lines,6 eyes by 1 line and the whole average VA improved by 2.3 lines.During 1-3 months after the treatment,observed by indirect funduscopy,the ME disappeared in 16 eyes,alleviated in 19 eyes and worsened in 2 eyes.In the final visit,ME disappeared in 19 eyes,alleviated in 17eyes and aggravated in 1 eye.Fifteen patients without a history of glaucoma developed ocular hypertension of 35.4 mmHg(25.1-40.1 mmHg,1 mmHg=0.133 kPa) at 1 week up to 6 months after injection,and 13 eyes required glaucoma medication.Trabeculectomy was performed on 4 eyes with glaucoma.Nine of 32 phakic eyes showed progression of posterior capsule cataract,4 of which underwent cataract extraction.All injections resulted in reduction in central foveal thickness as determined by OCT.The mean central foveal thickness decreased to 46% of preinjection values(n = 23,687μm vs.322 μm,respectively;P < 0.001) .The VA of the 4 ischemic CRVO patients did not improve.CONCLUSION:Intravitreal TA may be effective in treating ME caused by CRVO.Subjects with ischemic central retinal vein were less likely to have visual improvement.